Emerging Biomarkers of Acute Myocardial Infarction, An Overview of the Newest MicroRNAs

Galen Med J. 2023 May 30:12:1-7. doi: 10.31661/gmj.v12i0.2909. eCollection 2023.


Globally, acute myocardial infarction (AMI) is the leading cause of death. Early and precise diagnosis is essential for medical care to enhance prognoses and reduce mortality. The diagnosis of AMI relies primarily on conventional circulating biomarkers. However, these markers have many drawbacks. Non-coding RNAs (ncRNAs) form a significant fraction of the transcriptome and have been shown to be essential for many biological processes, including the pathogenesis of the disease. ncRNAs can be utilized as biomarkers due to their important role in the disease's development. The current manuscript describes recent progress on the role of ncRNAs as new AMI biomarkers.

Keywords: Biomarker; LcnRNA; Myocardial.